Literature DB >> 6626493

Excretion of oxprenolol and timolol in breast milk.

J Fidler, V Smith, M De Swiet.   

Abstract

The excretion of oxprenolol and timolol in breast milk was examined by comparing their concentrations in milk with those in plasma. The mean milk to plasma ratio of oxprenolol was 0.29 (SD 0.14; that for timolol was 0.80 (SD 0.21). The total quantity of either drug ingested by a fully breast-fed infant is unlikely to be therapeutically significant.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626493     DOI: 10.1111/j.1471-0528.1983.tb06771.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  7 in total

1.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

3.  Antihypertensive drugs in pregnancy.

Authors:  M deSwiet
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-10

4.  Transfer of labetalol into amniotic fluid and breast milk in lactating women.

Authors:  N O Lunell; J Kulas; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 6.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 7.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.